Effect of Sildenafil on hypertensive lower oesophageal sphincter

European Journal of Clinical Investigation

Volumn 32, Issue 9, 2002, Pages 682-685

  Bortolotti, Mauro ^a,c   Pandolfo, N ^b   Giovannini, M ^a   Mari, C ^a   Miglioli, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c University of Bologna ^*  (Italy)

Author keywords

Gastrointestinal motility; Lower oesophageal sphincter; Nitric oxide; Oesophagus; Phosphodiesterase; Sildenafil

Indexed keywords

PLACEBO; SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESOPHAGUS MOTILITY; ESOPHAGUS SPASM; FEMALE; HUMAN; HYPERTENSIVE LOWER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; MANOMETRY; MUSCLE TONE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOUBLE-BLIND METHOD; ESOPHAGEAL DISEASES; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; HYPERTENSION; MALE; MANOMETRY; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES;

EID: 0037000738     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01059.x     Document Type: Article

References (12)

1. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. New Engl J Med 1998;338:1397-404.
2. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phopshodiesterase type 5 in human corpus cavernosum muscle cells. Life Sci 1998;62:309-18.
3. Du C, Murray J, Conklin JL. Cyclic GMP mediates nitric oxide produced NANC hyperpolarization of opossum esophageal circular smooth muscle. Gastroenterology 1992;102:443A.
4. Tottrup MA, Knudsen MA, Madse G, Anderssori KE, Forman A. The role of the 1-arginine-nitric oxide pathway for relaxation of the human lower esophageal sphincter. Gastroenterology 1992;102:527A.
5. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995;109:1241-8.
6. Konturek JW, Thor P, Lukaszyk A, Gabryelewicz A, Konturek SJ, Domschke W. Endogenous nitric oxide in the control of esophageal motility in humans. J Physiol Pharmacol 1997;48:201-9.
7. Anand N, Paterson WG. Nitrix oxide (NO) is the mediator of physiological lower esophageal sphincter relaxation (LESR) in vivo. Gastroenterology 1992;102:415A.
8. Janssens J, Sifrim D, Lerut A. Esophageal motility disorders: a pathophysiological concept. Gastroenterology 1995;108:A621.
9. Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M. Effect of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology, 2000;118:253-7.
10. Bortolotti M, Lopilato C, Porrazzo G, Miglioli M. Effect of sildenafil on esophageal motility of normal subjects. Gastroenterology 2000: 118,A/4770.
11. Gelfond M, Rozen P, Keren S, Gilat T. Effect of nitrates on LES pressure in achalasia: a potential therapeutic aid. Gut 1981;22:312-8.
12. Bortolotti M, Labò G. Clinical and manometric effects of nifedipine in patients with achalasia. Gastroenterology 1981;80:39-44.